Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nat Commun. 2016 08 09; 7:12498.

View in: PubMed